NCT07308795 The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength
| NCT ID | NCT07308795 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Physical Medicine Rehabilitation Training and Research Hospital |
| Condition | Parkinson Disease (PD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-12-29 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 36 participants in total. It began in 2025-12-29 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson's disease is a neurodegenerative disorder characterized by both motor and non-motor symptoms. The involvement of respiratory muscles can lead to impairments in respiratory function in these patients. In this study is to evaluate the thickness of abdominal accessory respiratory muscles using ultrasonography in patients with Parkinson's disease. Additionally, the relationship between disease severity and expiratory respiratory muscle strength will be examined. The study will include Parkinson's patients at different stages of the disease, with respiratory muscle thickness measured via ultrasonography. The collected data will then be compared with disease severity and expiratory muscle strength.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * Parkinson's disease diagnosis with Modified Hoehn and Yahr stages 1-2-3 * Mini-Mental State Examination (MMSE) score \> 23 * Body Mass Index (BMI) \< 30 Exclusion Criteria: * Active smokers * Individuals with a diagnosis of active chest disease * Those with hemodynamic instability * Individuals with unstable vital signs * Parkinson's patients who cannot be controlled with medical treatment * Parkinson Plus syndromes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07308795 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Parkinson Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07308795 currently recruiting?
Yes, NCT07308795 is actively recruiting participants. Contact the research team at aysenuryigit885@gmail.com for enrollment information.
Where is the NCT07308795 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07308795 clinical trial?
NCT07308795 is sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. The trial plans to enroll 36 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.